Recent News

The FDA Requests Allergan Voluntarily Recall

In August 2019, the Food and Drug Administration (FDA) requested that Allergan recall its BIOCELL textured breast implants and tissue expanders due to an increased risk of cancer among implant patients. Here, the product and medical device  liability litigation attorneys at Peter Angelos P.C. discuss the connection between Allergan’s BIOCELL products and the increased risk…

Read More...

Continuation of Monsanto Dicamba Litigation Updates

In August 2019, environmentally conscious public-interest organizations filed a lawsuit against the U.S. Environmental Protection Agency and agrochemical company, Monsanto, after the approval of a pesticide meant for use on soybean and cotton plants. Here, the environmental litigation attorneys at Peter Angelos P.C. discuss the controversy surrounding the damaging dicamba pesticide and how the EPA’s…

Read More...

Updates on Studies Concerning Link Between Breast Cancer and Implants

In July 2019, pharmaceutical manufacturer Allergan ordered a recall of its BIOCELL textured breast implants after reports that the implants were linked to a serious cancer affecting hundreds of patients. Here, the pharmaceutical liability attorneys at Peter Angelos P.C. discuss recent updates to this serious event as well as your legal options if you have…

Read More...

Juul Facing Litigation Concerning Death of 18-Year-Old

Amidst the growing litigation against Juul Labs, the e-cigarette powerhouse is now facing a lawsuit in regards to the death of an 18-year old Florida teenager who died after using vaping devices. Here, the attorneys at Peter Angelos, P.C. detail recent updates to ongoing Juul litigation and as well as insights to the first major…

Read More...

FDA Issues a Class I Recall of the ROSA Brain 3.0 Robotic Surgery System by Zimmer Biomet

Medical device company Zimmer Biomet recently issued a Class I recall of the ROSA Brain 3.0 Robotic Surgery System due to a major software issue that caused the device to malfunction. The malfunction could cause serious injury or even death to patients receiving neurosurgery that utilizes the device. Here, the medical product liability attorneys at…

Read More...

The FDA Releases Safer Alternatives to Zantac As Investigation Into Contaminated Ranitidine-Based Medication Continues

As the FDA continues its investigation into the carcinogenic contamination of Zantac and other ranitidine-based drugs, the agency also released an extensive list of alternative medications that are deemed safe from toxic contaminants. Here, the Baltimore pharmaceutical liability attorneys at Peter Angelos, P.C. discuss updates to the Zantac contamination investigation as well as provide an…

Read More...

Updates Surrounding Groundwater Contamination Litigation

In 2018, 3M Company agreed to settle decades-long litigation surrounding the contamination of the groundwater in the east metro of Minnesota. Here, the environmental litigation attorneys at The Law Offices of Peter Angelos P.C. detail recent updates to ongoing groundwater contamination litigation as well as the environmental repercussions of unethical and unsustainable practices by large…

Read More...

An Overview of the FDA Death Database Malfunction

Researchers have reported that the miscategorization of a slew of patient deaths by the FDA points to the potential unreliability of their adverse events database. Here, the pharmaceutical liability attorneys at The Law Offices of Peter Angelos discuss how current protocols for reporting patient death through the FDA’s Manufacturer and User Facility Device Experience (MAUDE)…

Read More...

More Manufacturers Pull Generic Zantac Over Carcinogen Concerns

Manufacturers such as GlaxoSmithKline are pulling generic forms of Zantac off of the market, after Novartis’ Sandoz Inc. issued a voluntary recall earlier this week due to confirmed carcinogen contamination.  Here, the pharmaceutical liability attorneys at The Law Offices of Peter Angelos discuss the updates to the ongoing Zantac claims. GlaxoSmithKline has stopped global distribution…

Read More...

Zantac Manufacturer Recalls Medication Due to Confirmed Contamination

Sandoz Inc. has voluntarily recalled the generic version of common medication Zantac after the medication was confirmed to be contaminated with a human carcinogen. Here, the pharmaceutical liability attorneys at The Law Offices of Peter Angelos discuss the updates to the ongoing Zantac claims.  Global health regulators recently raised concerns about the possibility that the…

Read More...